AstraZeneca (AZN) has signed a global exclusive licence agreement with Dizal to acquire worldwide rights to develop and commercialise Zegfrovy, also known as sunvozertinib. The deal comprises a $600 million upfront payment
More
The pharmaceutical distribution sector is undergoing a significant transformation, driven by the need to balance highly targeted delivery models with large-scale operational demands. Modern drug supply chains are increasingly complex, requiring distributors
More
On April 15, the U.S. Department of Justice announced the sentencing of two U.S. nationals in U.S. v. Wang in the District of Massachusetts for operating laptop farms that enabled North Korean
More
The Federal Aviation Administration has proposed ending its long-standing prohibition on overland civil supersonic flight, replacing the blanket ban with a performance-based noise standard. The FAA originally established the prohibition in 1973
More
Rebecca Slaughter, the former Federal Trade Commission commissioner fired by Donald Trump without cause, is publicly criticising Yale University over its reported settlement talks with the Trump administration. Slaughter made her remarks
More
BP has revealed an additional $1bn (£750m) write-down from its struggling energy transition division, dealing another blow to the embattled oil giant. The FTSE 100-listed company said it expected to write down
More
CAVA Group has emerged as the standout performer among modern fast food stocks following the latest round of first-quarter earnings reports. The Mediterranean fast-casual chain, traded on the New York Stock Exchange
More
Quantum computing is emerging as one of the most closely watched sectors in technology investment circles, drawing significant attention from analysts and institutional investors alike. The United States government has been ramping
More
Rank Group, the owner of Grosvenor casinos, has reduced its workforce and slashed costs following the government’s decision to sharply raise online gambling taxes. Chancellor Rachel Reeves increased the Remote Gaming Duty
More
GSK is preparing to seek FDA accelerated approval for its cancer drug Jemperli after a phase 2 trial delivered a significant clinical win in a high-profile cancer indication. Interim results from the
More